Genomelink vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
DNA app store enabling users to upload Ancestry/23andMe raw data for additional trait and health insights; $3.3M revenue positioned to capture 23andMe users after its 2024 bankruptcy filing.
About
Genomelink is a San Francisco-based DNA app store and personalized genomics platform that allows users to upload raw DNA data from Ancestry, 23andMe, or other consumer DNA tests and access a marketplace of analysis apps covering ancestry, traits, health predispositions, and wellness insights. Founded in 2017 and backed by $4.5-9 million from 500 Global, Asymmetry Ventures, and 27 total investors, Genomelink generated $3.3 million in revenue in 2024 with a 22-person team, serving consumers who want more from their raw genetic data than the original testing company provides.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.